Showing results (961-970 of 1,254) with videos related to
Sort By:
Pageof 126
Cancer Treatment and Research Communications|August 22, 2020
Improvement in overall survival with Apalutamide, Darolutamide and Enzalutamide in patients with non-metastatic castration-resistant prostate cancerUmang Swami, Neeraj AgarwalCancer Treatment and Research Communications|March 26, 2021
Pre-diagnosis and early post-diagnosis dietary soy isoflavone intake and survival outcomes: A prospective cohort study of early stage breast cancer survivorsSuzanne C Ho, Winnie Yeo, William Goggins, et al.Cancer Treatment and Research Communications|March 26, 2021
In vivo potential of recombinant granulysin against human melanomaSameer Al-Wasaby, Patricia Guerrero-Ochoa, Raquel Ibáñez-Pérez, et al.Cancer Treatment and Research Communications|August 5, 2020
KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysisRebecca Ellen Goulding, Matthew Chenoweth, Gebra Cuyun Carter, et al.Cancer Treatment and Research Communications|March 30, 2023
The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinomaMahshid Panahi, Fereshteh Rezagholizadeh, Shabnam Mollazadehghomi, et al.Cancer Treatment and Research Communications|April 30, 2023
Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangementQing-Yun Gao, Fa-Man Xiao, Xiao-Cheng Lin, et al.Cancer Treatment and Research Communications|August 18, 2020
Impact of affordable care act on the treatment and outcomes for stage-IV colorectal cancerThejus T Jayakrishnan, Veli Bakalov, Zena Chahine, et al.Cancer Treatment and Research Communications|July 4, 2020
Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experienceNicolò Matteo Luca Battisti, Frances Rogerson, Karla Lee, et al.Cancer Treatment and Research Communications|April 21, 2021
Survival predictors and outcomes of patients with recurrent and/or metastatic head and neck cancer treated with chemotherapy plus cetuximab as first-line therapy: A real-world retrospective studyFilipa Pontes, Ana Rita Garcia, Isabel Domingues, et al.Cancer Treatment and Research Communications|April 13, 2021
Efficacy and safety of Prostate stereotactic body radiotherapy for metastatic castration-resistant prostate cancer: A prospective cohort studyJun Li, JunYong Dai, Peng Xian, et al.Pageof 126